NCT04062656 2024-03-12
IMAGINE
University Hospital, Essen
Phase 2 Unknown
Clinical Trials
14 trialsNCT04999332 2023-11-15
LOTS
National Cheng-Kung University Hospital
Phase 2 Unknown
NCT02934464 2021-09-13
ARMANI
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3 Unknown
NCT04393584 2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT04442984 2021-04-13
IRIGA
Blokhin's Russian Cancer Research Center
Phase 2 Unknown
NCT04354662 2021-02-18
Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT01271582 2019-01-29
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
Asan Medical Center
Phase 4 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT02855788 2016-08-04
Metronomic Chemotherapy in Advanced Gastric Cancer
Huashan Hospital
Phase 2 Unknown
NCT01980407 2015-03-05
Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer
Jilin Provincial Tumor Hospital
Phase 2 Unknown
NCT00005607 2013-12-19
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01160419 2010-10-28
Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT00270543 2009-02-09
An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
Far Eastern Memorial Hospital
Phase 2 Unknown
NCT00384878 2009-02-09
Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
Far Eastern Memorial Hospital
Phase 2 Unknown